Author

M. Lanzafame

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Temocillin for the Treatment of Urinary Tract Infections: First Italian Data from a Multicentre Real-World Experience

Background: Temocillin is a narrow-spectrum β-lactam with activity against extended-spectrum β-lactamase (ESBL)- and AmpC-producing Enterobacterales and represents a potential carbapenem-sparing option, especially for urinary tract infections (UTIs). This multicentre study evaluated the real-world use, clinical outcome...

Nicola Benvenuto, Massimiliano Lanzafame, S. Venturini et al. · Antibiotics · 0 citations

Review Open access Oct 2026

The unmet need for long-acting, narrow-spectrum antibiotics: a narrative review and call to action for antimicrobial stewardship

Abstract Long-acting lipoglycopeptides (laLGPs) are classified as Reserve agents under the WHO AWaRe framework, yet they are increasingly used as consolidation and suppressive therapy for Gram-positive bacteremia, endocarditis, and device-related infection caused by organisms that remain fully susceptible to first-line...

Giovanni Mori, S. Urru, Alessandro Castelli et al. · Antimicrobial Stewardship an... · 0 citations

Sep 2026

Mapping HIV infection and sex-based differences among sub-Saharan African migrants in Northeast Italy: a multicenter study.

HIV continues to disproportionately affect Sub-Saharan African (SSA) migrants in Italy, who often experience late diagnosis and complex clinical and social challenges. This multicenter cross-sectional study evaluated determinants of poor immunological and virological outcomes and sex-based differences among 762 SSA mig...

Anna Ferrari, Marco Cola, Claudia Cozzolino et al. · Pathogens and Global Health · 0 citations